|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
GNLX | Yu Yong | VP, Clinical Trial Operations | Dec 15 | Sale | 13.16 | 32,535 | 428,180 | 0 | Dec 18 04:15 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Dec 07 | Sale | 11.85 | 36,800 | 435,995 | 32,535 | Dec 08 05:57 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Nov 21 | Sale | 10.26 | 18,665 | 191,555 | 69,335 | Nov 22 04:15 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Oct 24 | Option Exercise | 6.00 | 5,200 | 31,200 | 111,335 | Oct 25 04:15 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Oct 24 | Sale | 19.11 | 5,200 | 99,351 | 106,135 | Oct 25 04:15 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Oct 10 | Option Exercise | 6.00 | 5,200 | 31,200 | 111,335 | Oct 11 04:10 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Oct 10 | Sale | 22.01 | 5,200 | 114,462 | 106,135 | Oct 11 04:10 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 26 | Option Exercise | 6.00 | 5,200 | 31,200 | 111,335 | Sep 27 04:10 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 26 | Sale | 23.56 | 5,200 | 122,528 | 106,135 | Sep 27 04:10 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 20 | Option Exercise | 6.00 | 6,000 | 36,000 | 112,135 | Sep 21 04:35 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 20 | Sale | 27.96 | 6,000 | 167,786 | 106,135 | Sep 21 04:35 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 15 | Option Exercise | 6.00 | 10,400 | 62,400 | 116,535 | Sep 18 08:13 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 15 | Sale | 21.89 | 10,400 | 227,630 | 106,135 | Sep 18 08:13 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Sep 13 | Sale | 21.14 | 29,800 | 629,927 | 106,135 | Sep 15 08:06 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Aug 30 | Sale | 24.70 | 19,800 | 489,060 | 135,935 | Aug 30 07:22 PM |
GNLX | Yu Yong | VP, Clinical Trial Operations | Aug 18 | Sale | 23.73 | 3,265 | 77,478 | 155,735 | Aug 22 04:14 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite